Y-Intercept (HK)’s Gilead Sciences GILD Stock Holding History

Y-Intercept (HK)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.2M	Sell	57,007 -47,286	-45%	-$6.23M	0.14%	170
2026 Q1	$14.5M	Buy	+104,293	New	+$14.6M	0.28%	50
2025 Q4	–	Sell	-13,131	Closed	-$1.46M	–	1706
2025 Q3	$1.46M	Buy	+13,131	New	+$1.49M	0.04%	785
2024 Q2	–	Sell	-26,429	Closed	-$1.94M	–	1567
2024 Q1	$1.94M	Buy	26,429 +19,824	+300%	+$1.52M	0.15%	176
2023 Q4	$535K	Buy	+6,605	New	+$514K	0.05%	567
2023 Q3	–	Sell	-11,089	Closed	-$855K	–	1237
2023 Q2	$855K	Buy	+11,089	New	+$884K	0.09%	360
2022 Q4	–	Sell	-25,320	Closed	-$1.56M	–	1120
2022 Q3	$1.56M	Buy	+25,320	New	+$1.6M	0.16%	200
2022 Q1	–	Sell	-16,324	Closed	-$1.19M	–	800
2021 Q4	$1.19M	Buy	+16,324	New	+$1.12M	0.28%	91
2021 Q3	–	Sell	-25,993	Closed	-$1.79M	–	745
2021 Q2	$1.79M	Buy	25,993 +14,181	+120%	+$947K	0.46%	26
2021 Q1	$774K	Buy	+11,812	New	+$762K	0.21%	152

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Y-Intercept (HK)'s GILD Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Gilead Sciences (GILD) stake by 45% in Q2 2026, selling an estimated $6.23M and leaving 57,007 shares worth $7.2M. The position accounts for 0.14% of the portfolio, ranked #170.

Y-Intercept (HK) first reported a position in GILD in Q1 2021 and has held it in 10 quarters since. The position peaked at $14.5M in Q1 2026. 709 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Y-Intercept (HK) held 57,007 shares of Gilead Sciences worth $7.2M as of Q2 2026.
Y-Intercept (HK) sold 47,286 Gilead Sciences shares in Q2 2026, an estimated $6.23M.
Gilead Sciences made up 0.14% of Y-Intercept (HK)'s portfolio in Q2 2026, its #170 holding.
Y-Intercept (HK) first reported a position in Gilead Sciences in Q1 2021 and has held it in 10 quarters since.
Y-Intercept (HK)'s Gilead Sciences position peaked at $14.5M in Q1 2026.
709 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.